+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Drug Infusion Systems Market - Global Forecast to 2030- Product Image
Drug Infusion Systems Market - Global Forecast to 2030- Product Image
Sale

Drug Infusion Systems Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 180 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5967874
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Drug Infusion Systems Market grew from USD 24.01 billion in 2024 to USD 25.70 billion in 2025. It is expected to continue growing at a CAGR of 6.77%, reaching USD 35.58 billion by 2030.

The drug infusion systems market has entered a phase of rapid transformation driven by technological breakthroughs, evolving patient needs, and shifting regulatory landscapes. In an era where precision medicine and patient-centric care are at the forefront, infusion pumps and disposables have moved beyond simple fluid delivery to intelligent, connected platforms that enhance safety, efficiency, and clinical outcomes. This introduction presents a concise overview of the market’s current dynamics, highlighting the convergence of innovative hardware, software integration, and data analytics. It emphasizes how breakthroughs in miniaturization and wireless connectivity are empowering healthcare professionals to manage complex therapeutic regimens with greater accuracy and confidence. As stakeholders seek to optimize resource utilization and improve patient satisfaction, a deeper understanding of these foundational trends is essential. This section lays the groundwork for a comprehensive exploration of transformative shifts, regulatory impacts, segmentation strategies, and actionable recommendations that will guide decision-makers in leveraging emerging opportunities and mitigating risks in the evolving infusion landscape.

Transformative Shifts in the Infusion Systems Landscape

Over the past decade, three major forces have reshaped the infusion systems market: digital convergence, regulatory tightening, and a shift toward home-based care. First, the integration of smart sensors, cloud platforms, and artificial intelligence has transformed standalone pumps into interoperable nodes within comprehensive care ecosystems. This shift has not only improved dosing accuracy but also enabled predictive maintenance and remote monitoring, reducing downtime and improving patient safety. Second, regulators worldwide have introduced more stringent standards for cybersecurity, interoperability, and device usability, prompting manufacturers to invest heavily in quality assurance and compliance frameworks. Finally, the rise of outpatient and home infusion therapies has prompted a portfolio realignment, with ambulatory and wearable devices gaining traction over traditional hospital-grade pumps. These transformative shifts underscore a fundamental transition from episodic, hospital-centric infusions to continuous, patient-empowered treatment models. As a result, market participants must adapt strategies that balance innovation with affordability, ensuring seamless integration into diverse care settings while maintaining rigorous safety standards.

Cumulative Impact of United States Tariffs 2025

In 2025, newly implemented U.S. tariffs have introduced a complex layer of cost pressures across the infusion systems value chain. Over 25% levies on electronic components and medical-grade plastics have increased production expenses, compelling manufacturers to reassess supply chain strategies and negotiate with overseas suppliers. These tariffs have prompted a dual response: some companies have localized assembly operations to mitigate duty impacts, while others have absorbed incremental costs to maintain competitive pricing. Importers of elastomeric and single-use disposable pumps have encountered margin erosion, driving innovation in alternative materials and design efficiency. Additionally, healthcare providers facing higher acquisition costs have negotiated bundled service agreements or extended device lifecycles to preserve budgetary allocations. Despite these headwinds, the tariffs have accelerated strategic shifts toward vertical integration and regional sourcing, fostering resilience but also requiring significant capital investment. Consequently, industry leaders must navigate a delicate balance between cost containment and continued investment in R&D to sustain long-term growth.

Key Segmentation Insights

A nuanced examination of product, application, end-user, technology, channel, and material dimensions reveals critical competitive advantages. Within product type, ambulatory infusion pumps-both body-worn and stationary-are capturing demand for home- and clinic-based therapies, while disposables such as elastomeric and single-use electronic pumps offer cost-effective, low-maintenance solutions for short-duration treatments. Patient-controlled analgesia pumps, available in wired and wireless variants, drive patient autonomy in pain management, whereas syringe and volumetric pumps continue to serve high-precision dosing requirements in hospital settings, differentiated by compact, standard, adult, and pediatric configurations. Therapeutic segmentation underscores oncology’s dominance in chemotherapy and targeted therapy protocols, anti-infective programs spanning antibiotic, antifungal, and antiviral delivery, plus specialized pediatric and parenteral nutrition applications. End users range from decentralized ambulatory care centers and outpatient clinics to in-home family- and professional-managed settings, supported by private and public hospitals and dedicated nursing facilities. Technology frameworks differentiate between standalone mechanical systems and advanced smart platforms with wireless connectivity-Bluetooth and Wi-Fi-alongside wearable patches and strap-on devices. Distribution channels traverse direct manufacturer-to-consumer models, large- and regional distributors, e-commerce platforms, and chain versus independent pharmacies. Material innovations focus on thermoset and thermoplastic elastomers, BPA-free and standard PVC, medical- grade silicone variants, and diverse TPU grades, aligning biocompatibility with sustainability goals.

Key Regional Insights

Regional dynamics vary substantially as providers and payers grapple with distinct regulatory, reimbursement, and infrastructure environments. In the Americas, robust funding for oncology and pain management therapies underpins strong uptake of smart infusion systems, especially in private hospitals and ambulatory centers. Latin American markets, meanwhile, emphasize cost-efficient disposables and rely heavily on distribution partnerships to bridge coverage gaps. Europe, Middle East & Africa presents a heterogeneous terrain: Western Europe prioritizes integrated healthcare networks and digital interoperability, driving demand for Wi-Fi enabled pumps, while emerging markets in Eastern Europe and MEA focus on basic volumetric and gravity-based systems, seeking external funding to upgrade legacy fleets. The Asia-Pacific region exhibits the fastest growth trajectory, propelled by expanding home care services in Japan and Australia, rapid hospital expansion in China and India, and government subsidies that promote local manufacturing of medical-grade plastics. Across all regions, telemedicine integration and post-pandemic preparedness continue to influence procurement strategies, reinforcing the importance of scalable, adaptable infusion platforms.

Key Companies Insights

Market leadership is structured around established multinationals and innovative challengers. AKAS Infusions, B. Braun SE, Baxter International, Inc., and Becton, Dickinson, and Company command substantial share with diversified portfolios spanning smart smart pumps, disposables, and infusion software. Fresenius Kabi AG and Fresenius SE & Co. KGaA leverage integrated healthcare services to bundle infusion therapies with clinical support, while Medtronic Plc and Terumo Corporation emphasize advanced sensor technologies and data analytics. ICU Medical Inc., Micrel Medical Devices SA, and Ivenix Inc. are gaining momentum through patient-centric hardware that simplifies programming and alerts. Flowonix Medical Inc. and Intera Oncology Inc. specialize in localized drug delivery platforms, and Teleflex Incorporated and Halyard Health, Inc. focus on disposables with enhanced biocompatibility. Emerging players such as Debiotech S.A., Eitan Medical, IRADIMED CORPORATION, Microport Scientific Corporation, Promecon GmbH, SINO MDT, Smiths Group plc, Tandem Diabetes Care, Inc., and Terumo Corporation’s subsidiaries drive niche innovations in wearable tech and wireless connectivity. As competition intensifies, strategic collaborations, M&A, and differentiation through service-based models will dictate market leadership trajectories.

Actionable Recommendations for Industry Leaders

To maintain a competitive edge, industry leaders should: 1) Prioritize modular platform design, enabling rapid customization for diverse therapeutic areas and end-user environments. 2) Invest in cybersecurity and interoperability standards to ensure seamless integration with electronic health records and telehealth systems. 3) Strengthen regional supply chains by establishing local assembly hubs and forging partnerships with validated raw material suppliers. 4) Expand service portfolios to include post-installation training, remote monitoring, and predictive maintenance, transforming one-time sales into recurring revenue streams. 5) Explore co-development agreements with biopharma firms to embed smart infusion capabilities within novel drug delivery protocols. 6) Adopt sustainable materials and recycling initiatives to meet emerging ESG benchmarks and enhance brand reputation among environmentally conscious stakeholders. By executing these targeted actions, decision-makers can align operations with evolving market demands and regulatory expectations.

Conclusion

Throughout this executive summary, we have traced the evolution of drug infusion systems from mechanical workhorses to intelligent, connected care enablers. We examined transformative trends-digital convergence, regulatory rigor, and care decentralization-while unpacking tariff-induced cost challenges. Our segmentation analysis illuminated growth pockets across products, therapies, end users, technologies, distribution routes, and materials. Regional insights highlighted the Americas’ focus on oncology and home care, EMEA’s infrastructure-driven disparities, and Asia-Pacific’s rapid adoption enabled by government support. We reviewed a competitive landscape anchored by global incumbents and agile innovators, and outlined concrete recommendations for modular design, cybersecurity, supply chain resilience, and sustainability. Together, these insights equip stakeholders with the strategic context needed to navigate complexity, capitalize on emerging opportunities, and foster patient-centric outcomes in an increasingly interconnected infusion ecosystem.

Market Segmentation & Coverage

This research report categorizes the Drug Infusion Systems Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Ambulatory Infusion Pumps
    • Body-Worn Ambulatory Infusion Pumps
    • Stationary Ambulatory Infusion Pumps
  • Disposable Infusion Pumps
    • Elastomeric Infusion Pumps
    • Single-Use Electronic Infusion Pumps
  • Patient-Controlled Analgesia (PCA) Pumps
    • Wired PCA Pumps
    • Wireless PCA Pumps
  • Syringe Infusion Pumps
    • Compact Syringe Infusion Pumps
    • Standard Syringe Infusion Pumps
  • Volumetric Infusion Pumps
    • Adult Volumetric Infusion Pumps
    • Pediatric Volumetric Infusion Pumps
  • Anti-Infective
    • Antibiotic Delivery
    • Antifungal Delivery
    • Antiviral Delivery
  • Oncology
    • Chemotherapy
    • Targeted Therapy
  • Pain Management
    • Acute Pain
    • Chronic Pain
  • Pediatric Infusion
    • Acute Conditions
    • Chronic Conditions
  • Total Parenteral Nutrition (TPN)
    • Home Parenteral Nutrition
    • Hospital Parenteral Nutrition
  • Ambulatory Care Centers
    • Agglomerated Centers
    • Decentralized Centers
  • Clinics
    • Outpatient Clinics
    • Specialized Clinics
  • Home Care Settings
    • Family-Managed Home Care
    • Professional Home Care
  • Hospitals
    • Private Hospitals
    • Public Hospitals
  • Skilled Nursing Facilities
    • General Nursing Facilities
    • Specialty Nursing Facilities
  • Smart Infusion Systems
    • Integrated Healthcare Solutions
    • Standalone Smart Pumps
  • Traditional Mechanical Infusion Systems
    • Gravity-Based Systems
    • Volume-Controlled Devices
  • Wearable Technology
    • Patch-Based Devices
    • Strap-On Devices
  • Wireless Connectivity
    • Bluetooth Enabled Pumps
    • Wi-Fi Enabled Pumps
  • Direct Sales
    • Manufacturer To Consumer
    • Manufacturer To Facility
  • Distributors
    • Large-Scale Distributors
    • Regional Distributors
  • Online Platforms
    • E-Tailers
    • Marketplace Platforms
  • Retail Pharmacies
    • Chain Pharmacies
    • Independent Pharmacies
  • Elastomer
    • Thermoplastic Elastomers
    • Thermoset Elastomers
  • Polyvinyl Chloride (PVC)
    • BPA-Free PVC
    • Standard PVC
  • Silicone
    • Medical Grade Silicone
    • Standard Silicone
  • Thermoplastic Polyurethane (TPU)
    • Soft Touch TPU
    • Standard TPU

This research report categorizes the Drug Infusion Systems Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Drug Infusion Systems Market to delves into recent significant developments and analyze trends in each of the following companies:

  • AKAS Infusions
  • B. Braun SE
  • Baxter International, Inc.
  • Becton, Dickinson, and Company
  • Debiotech S.A.
  • Eitan Medical
  • Flowonix Medical Inc.
  • Fresenius Kabi AG
  • Fresenius SE & Co. KGaA
  • Halyard Health, Inc.
  • ICU Medical Inc.
  • Insulet Corporation
  • Intera Oncology Inc.
  • IRADIMED CORPORATION
  • Ivenix Inc.
  • Medtronic Plc
  • Micrel Medical Devices SA
  • Microport Scientific Corporation
  • MOOG, Inc.
  • Promecon GmbH
  • SINO MDT
  • Smiths Group plc
  • Tandem Diabetes Care, Inc.
  • Teleflex Incorporated
  • Terumo Corporation

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Drug Infusion Systems Market, by Product Type
8.1. Introduction
8.2. Ambulatory Infusion Pumps
8.2.1. Body-Worn Ambulatory Infusion Pumps
8.2.2. Stationary Ambulatory Infusion Pumps
8.3. Disposable Infusion Pumps
8.3.1. Elastomeric Infusion Pumps
8.3.2. Single-Use Electronic Infusion Pumps
8.4. Patient-Controlled Analgesia (PCA) Pumps
8.4.1. Wired PCA Pumps
8.4.2. Wireless PCA Pumps
8.5. Syringe Infusion Pumps
8.5.1. Compact Syringe Infusion Pumps
8.5.2. Standard Syringe Infusion Pumps
8.6. Volumetric Infusion Pumps
8.6.1. Adult Volumetric Infusion Pumps
8.6.2. Pediatric Volumetric Infusion Pumps
9. Drug Infusion Systems Market, by Therapeutic Application
9.1. Introduction
9.2. Anti-Infective
9.2.1. Antibiotic Delivery
9.2.2. Antifungal Delivery
9.2.3. Antiviral Delivery
9.3. Oncology
9.3.1. Chemotherapy
9.3.2. Targeted Therapy
9.4. Pain Management
9.4.1. Acute Pain
9.4.2. Chronic Pain
9.5. Pediatric Infusion
9.5.1. Acute Conditions
9.5.2. Chronic Conditions
9.6. Total Parenteral Nutrition (TPN)
9.6.1. Home Parenteral Nutrition
9.6.2. Hospital Parenteral Nutrition
10. Drug Infusion Systems Market, by End User
10.1. Introduction
10.2. Ambulatory Care Centers
10.2.1. Agglomerated Centers
10.2.2. Decentralized Centers
10.3. Clinics
10.3.1. Outpatient Clinics
10.3.2. Specialized Clinics
10.4. Home Care Settings
10.4.1. Family-Managed Home Care
10.4.2. Professional Home Care
10.5. Hospitals
10.5.1. Private Hospitals
10.5.2. Public Hospitals
10.6. Skilled Nursing Facilities
10.6.1. General Nursing Facilities
10.6.2. Specialty Nursing Facilities
11. Drug Infusion Systems Market, by Technology
11.1. Introduction
11.2. Smart Infusion Systems
11.2.1. Integrated Healthcare Solutions
11.2.2. Standalone Smart Pumps
11.3. Traditional Mechanical Infusion Systems
11.3.1. Gravity-Based Systems
11.3.2. Volume-Controlled Devices
11.4. Wearable Technology
11.4.1. Patch-Based Devices
11.4.2. Strap-On Devices
11.5. Wireless Connectivity
11.5.1. Bluetooth Enabled Pumps
11.5.2. Wi-Fi Enabled Pumps
12. Drug Infusion Systems Market, by Channel
12.1. Introduction
12.2. Direct Sales
12.2.1. Manufacturer To Consumer
12.2.2. Manufacturer To Facility
12.3. Distributors
12.3.1. Large-Scale Distributors
12.3.2. Regional Distributors
12.4. Online Platforms
12.4.1. E-Tailers
12.4.2. Marketplace Platforms
12.5. Retail Pharmacies
12.5.1. Chain Pharmacies
12.5.2. Independent Pharmacies
13. Drug Infusion Systems Market, by Material
13.1. Introduction
13.2. Elastomer
13.2.1. Thermoplastic Elastomers
13.2.2. Thermoset Elastomers
13.3. Polyvinyl Chloride (PVC)
13.3.1. BPA-Free PVC
13.3.2. Standard PVC
13.4. Silicone
13.4.1. Medical Grade Silicone
13.4.2. Standard Silicone
13.5. Thermoplastic Polyurethane (TPU)
13.5.1. Soft Touch TPU
13.5.2. Standard TPU
14. Americas Drug Infusion Systems Market
14.1. Introduction
14.2. Argentina
14.3. Brazil
14.4. Canada
14.5. Mexico
14.6. United States
15. Asia-Pacific Drug Infusion Systems Market
15.1. Introduction
15.2. Australia
15.3. China
15.4. India
15.5. Indonesia
15.6. Japan
15.7. Malaysia
15.8. Philippines
15.9. Singapore
15.10. South Korea
15.11. Taiwan
15.12. Thailand
15.13. Vietnam
16. Europe, Middle East & Africa Drug Infusion Systems Market
16.1. Introduction
16.2. Denmark
16.3. Egypt
16.4. Finland
16.5. France
16.6. Germany
16.7. Israel
16.8. Italy
16.9. Netherlands
16.10. Nigeria
16.11. Norway
16.12. Poland
16.13. Qatar
16.14. Russia
16.15. Saudi Arabia
16.16. South Africa
16.17. Spain
16.18. Sweden
16.19. Switzerland
16.20. Turkey
16.21. United Arab Emirates
16.22. United Kingdom
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. AKAS Infusions
17.3.2. B. Braun SE
17.3.3. Baxter International, Inc.
17.3.4. Becton, Dickinson, and Company
17.3.5. Debiotech S.A.
17.3.6. Eitan Medical
17.3.7. Flowonix Medical Inc.
17.3.8. Fresenius Kabi AG
17.3.9. Fresenius SE & Co. KGaA
17.3.10. Halyard Health, Inc.
17.3.11. ICU Medical Inc.
17.3.12. Insulet Corporation
17.3.13. Intera Oncology Inc.
17.3.14. IRADIMED CORPORATION
17.3.15. Ivenix Inc.
17.3.16. Medtronic Plc
17.3.17. Micrel Medical Devices SA
17.3.18. Microport Scientific Corporation
17.3.19. MOOG, Inc.
17.3.20. Promecon GmbH
17.3.21. SINO MDT
17.3.22. Smiths Group plc
17.3.23. Tandem Diabetes Care, Inc.
17.3.24. Teleflex Incorporated
17.3.25. Terumo Corporation
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. DRUG INFUSION SYSTEMS MARKET MULTI-CURRENCY
FIGURE 2. DRUG INFUSION SYSTEMS MARKET MULTI-LANGUAGE
FIGURE 3. DRUG INFUSION SYSTEMS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY MATERIAL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. DRUG INFUSION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. DRUG INFUSION SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. DRUG INFUSION SYSTEMS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY AMBULATORY INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY BODY-WORN AMBULATORY INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY STATIONARY AMBULATORY INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY AMBULATORY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY DISPOSABLE INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY ELASTOMERIC INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY SINGLE-USE ELECTRONIC INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY DISPOSABLE INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY PATIENT-CONTROLLED ANALGESIA (PCA) PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY WIRED PCA PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY WIRELESS PCA PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY PATIENT-CONTROLLED ANALGESIA (PCA) PUMPS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY SYRINGE INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY COMPACT SYRINGE INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY STANDARD SYRINGE INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY SYRINGE INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY VOLUMETRIC INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY ADULT VOLUMETRIC INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY PEDIATRIC VOLUMETRIC INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY VOLUMETRIC INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY ANTI-INFECTIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY ANTIBIOTIC DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY ANTIFUNGAL DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY ANTIVIRAL DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY ANTI-INFECTIVE, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY ACUTE PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY PEDIATRIC INFUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY ACUTE CONDITIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY CHRONIC CONDITIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY PEDIATRIC INFUSION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY TOTAL PARENTERAL NUTRITION (TPN), BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY HOME PARENTERAL NUTRITION, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY HOSPITAL PARENTERAL NUTRITION, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY TOTAL PARENTERAL NUTRITION (TPN), 2018-2030 (USD MILLION)
TABLE 49. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY AGGLOMERATED CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY DECENTRALIZED CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY SPECIALIZED CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY FAMILY-MANAGED HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY PROFESSIONAL HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY SKILLED NURSING FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY GENERAL NURSING FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY SPECIALTY NURSING FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY SKILLED NURSING FACILITIES, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY SMART INFUSION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY INTEGRATED HEALTHCARE SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY STANDALONE SMART PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY SMART INFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY TRADITIONAL MECHANICAL INFUSION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY GRAVITY-BASED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY VOLUME-CONTROLLED DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY TRADITIONAL MECHANICAL INFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY WEARABLE TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY PATCH-BASED DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY STRAP-ON DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY WEARABLE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY WIRELESS CONNECTIVITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY BLUETOOTH ENABLED PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY WI-FI ENABLED PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 86. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY WIRELESS CONNECTIVITY, 2018-2030 (USD MILLION)
TABLE 87. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 88. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 89. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY MANUFACTURER TO CONSUMER, BY REGION, 2018-2030 (USD MILLION)
TABLE 90. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY MANUFACTURER TO FACILITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 91. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 92. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 93. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY LARGE-SCALE DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 94. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 95. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 96. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY ONLINE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 97. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY E-TAILERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 98. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY MARKETPLACE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 99. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY ONLINE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 100. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 101. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 102. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 103. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 104. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 105. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY ELASTOMER, BY REGION, 2018-2030 (USD MILLION)
TABLE 106. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY THERMOPLASTIC ELASTOMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 107. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY THERMOSET ELASTOMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 108. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY ELASTOMER, 2018-2030 (USD MILLION)
TABLE 109. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY POLYVINYL CHLORIDE (PVC), BY REGION, 2018-2030 (USD MILLION)
TABLE 110. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY BPA-FREE PVC, BY REGION, 2018-2030 (USD MILLION)
TABLE 111. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY STANDARD PVC, BY REGION, 2018-2030 (USD MILLION)
TABLE 112. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY POLYVINYL CHLORIDE (PVC), 2018-2030 (USD MILLION)
TABLE 113. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY SILICONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 114. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY MEDICAL GRADE SILICONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 115. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY STANDARD SILICONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 116. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY SILICONE, 2018-2030 (USD MILLION)
TABLE 117. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY THERMOPLASTIC POLYURETHANE (TPU), BY REGION, 2018-2030 (USD MILLION)
TABLE 118. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY SOFT TOUCH TPU, BY REGION, 2018-2030 (USD MILLION)
TABLE 119. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY STANDARD TPU, BY REGION, 2018-2030 (USD MILLION)
TABLE 120. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY THERMOPLASTIC POLYURETHANE (TPU), 2018-2030 (USD MILLION)
TABLE 121. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 122. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY AMBULATORY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 123. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY DISPOSABLE INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 124. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY PATIENT-CONTROLLED ANALGESIA (PCA) PUMPS, 2018-2030 (USD MILLION)
TABLE 125. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY SYRINGE INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 126. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY VOLUMETRIC INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 127. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY ANTI-INFECTIVE, 2018-2030 (USD MILLION)
TABLE 129. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 130. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 131. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY PEDIATRIC INFUSION, 2018-2030 (USD MILLION)
TABLE 132. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY TOTAL PARENTERAL NUTRITION (TPN), 2018-2030 (USD MILLION)
TABLE 133. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 134. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 135. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 136. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 137. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 138. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY SKILLED NURSING FACILITIES, 2018-2030 (USD MILLION)
TABLE 139. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 140. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY SMART INFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 141. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY TRADITIONAL MECHANICAL INFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 142. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY WEARABLE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 143. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY WIRELESS CONNECTIVITY, 2018-2030 (USD MILLION)
TABLE 144. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 146. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 147. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY ONLINE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 148. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 149. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 150. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY ELASTOMER, 2018-2030 (USD MILLION)
TABLE 151. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY POLYVINYL CHLORIDE (PVC), 2018-2030 (USD MILLION)
TABLE 152. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY SILICONE, 2018-2030 (USD MILLION)
TABLE 153. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY THERMOPLASTIC POLYURETHANE (TPU), 2018-2030 (USD MILLION)
TABLE 154. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 155. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 156. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY AMBULATORY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 157. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY DISPOSABLE INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 158. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY PATIENT-CONTROLLED ANALGESIA (PCA) PUMPS, 2018-2030 (USD MILLION)
TABLE 159. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY SYRINGE INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 160. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY VOLUMETRIC INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 161. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY ANTI-INFECTIVE, 2018-2030 (USD MILLION)
TABLE 163. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 164. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 165. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY PEDIATRIC INFUSION, 2018-2030 (USD MILLION)
TABLE 166. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY TOTAL PARENTERAL NUTRITION (TPN), 2018-2030 (USD MILLION)
TABLE 167. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 169. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 170. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 171. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 172. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY SKILLED NURSING FACILITIES, 2018-2030 (USD MILLION)
TABLE 173. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 174. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY SMART INFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 175. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY TRADITIONAL MECHANICAL INFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 176. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY WEARABLE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 177. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY WIRELESS CONNECTIVITY, 2018-2030 (USD MILLION)
TABLE 178. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 179. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 180. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 181. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY ONLINE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 182. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 183. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 184. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY ELASTOMER, 2018-2030 (USD MILLION)
TABLE 185. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY POLYVINYL CHLORIDE (PVC), 2018-2030 (USD MILLION)
TABLE 186. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY SILICONE, 2018-2030 (USD MILLION)
TABLE 187. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY THERMOPLASTIC POLYURETHANE (TPU), 2018-2030 (USD MILLION)
TABLE 188. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 189. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY AMBULATORY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 190. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY DISPOSABLE INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 191. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY PATIENT-CONTROLLED ANALGESIA (PCA) PUMPS, 2018-2030 (USD MILLION)
TABLE 192. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY SYRINGE INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 193. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY VOLUMETRIC INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 194. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 195. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY ANTI-INFECTIVE, 2018-2030 (USD MILLION)
TABLE 196. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 197. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 198. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY PEDIATRIC INFUSION, 2018-2030 (USD MILLION)
TABLE 199. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY TOTAL PARENTERAL NUTRITION (TPN), 2018-2030 (USD MILLION)
TABLE 200. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 201. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 202. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 203. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 204. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 205. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY SKILLED NURSING FACILITIES, 2018-2030 (USD MILLION)
TABLE 206. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 207. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY SMART INFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 208. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY TRADITIONAL MECHANICAL INFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 209. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY WEARABLE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 210. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY WIRELESS CONNECTIVITY, 2018-2030 (USD MILLION)
TABLE 211. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 212. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 213. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 214. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY ONLINE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 215. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 216. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 217. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY ELASTOMER, 2018-2030 (USD MILLION)
TABLE 218. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY POLYVINYL CHLORIDE (PVC), 2018-2030 (USD MILLION)
TABLE 219. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY SILICONE, 2018-2030 (USD MILLION)
TABLE 220. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY THERMOPLASTIC POLYURETHANE (TPU), 2018-2030 (USD MILLION)
TABLE 221. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 222. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY AMBULATORY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 223. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY DISPOSABLE INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 224. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY PATIENT-CONTROLLED ANALGESIA (PCA) PUMPS, 2018-2030 (USD MILLION)
TABLE 225. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY SYRINGE INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 226. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY VOLUMETRIC INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 227. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 228. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY ANTI-INFECTIVE, 2018-2030 (USD MILLION)
TABLE 229. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 230. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 231. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY PEDIATRIC INFUSION, 2018-2030 (USD MILLION)
TABLE 232. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY TOTAL PARENTERAL NUTRITION (TPN), 2018-2030 (USD MILLION)
TABLE 233. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 234. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 235. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 236. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 237. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 238. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY SKILLED NURSING FACILITIES, 2018-2030 (USD MILLION)
TABLE 239. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 240. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY SMART INFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 241. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY TRADITIONAL MECHANICAL INFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 242. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY WEARABLE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 243. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY WIRELESS CONNECTIVITY, 2018-2030 (USD MILLION)
TABLE 244. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 245. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 246. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 247. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY ONLINE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 248. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 249. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 250. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY ELASTOMER, 2018-2030 (USD MILLION)
TABLE 251. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY POLYVINYL CHLORIDE (PVC), 2018-2030 (USD MILLION)
TABLE 252. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY SILICONE, 2018-2030 (USD MILLION)
TABLE 253. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY THERMOPLASTIC POLYURETHANE (TPU), 2018-2030 (USD MILLION)
TABLE 254. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 255. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY AMBULATORY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 256. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY DISPOSABLE INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 257. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY PATIENT-CONTROLLED ANALGESIA (PCA) PUMPS, 2018-2030 (USD MILLION)
TABLE 258. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY SYRINGE INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 259. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY VOLUMETRIC INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 260. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 261. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY ANTI-INFECTIVE, 2018-2030 (USD MILLION)
TABLE 262. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 263. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 264. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY PEDIATRIC INFUSION, 2018-2030 (USD MILLION)
TABLE 265. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY TOTAL PARENTERAL NUTRITION (TPN), 2018-2030 (USD MILLION)
TABLE 266. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 267. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 268. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 269. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 270. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 271. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY SKILLED NURSING FACILITIES, 2018-2030 (USD MILLION)
TABLE 272. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 273. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY SMART INFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 274. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY TRADITIONAL MECHANICAL INFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 275. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY WEARABLE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 276. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY WIRELESS CONNECTIVITY, 2018-2030 (USD MILLION)
TABLE 277. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 278. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 279. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 280. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY ONLINE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 281. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 282. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 283. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY ELASTOMER, 2018-2030 (USD MILLION)
TABLE 284. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY POLYVINYL CHLORIDE (PVC), 2018-2030 (USD MILLION)
TABLE 285. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY SILICONE, 2018-2030 (USD MILLION)
TABLE 286. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY THERMOPLASTIC POLYURETHANE (TPU), 2018-2030 (USD MILLION)
TABLE 287. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 288. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY AMBULATORY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 289. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY DISPOSABLE INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 290. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY PATIENT-CONTROLLED ANALGESIA (PCA) PUMPS, 2018-2030 (USD MILLION)
TABLE 291. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY SYRINGE INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 292. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY VOLUMETRIC INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 293. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 294. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY ANTI-INFECTIVE, 2018-2030 (USD MILLION)
TABLE 295. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 296. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 297. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY PEDIATRIC INFUSION, 2018-2030 (USD MILLION)
TABLE 298. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY TOTAL PARENTERAL NUTRITION (TPN), 2018-2030 (USD MILLION)
TABLE 299. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 300. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 301. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 302. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 303. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 304. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY SKILLED NURSING FACILITIES, 2018-2030 (USD MILLION)
TABLE 305. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 306. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY SMART INFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 307. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY TRADITIONAL MECHANICAL INFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 308. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY WEARABLE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 309. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY WIRELESS CONNECTIVITY, 2018-2030 (USD MILLION)
TABLE 310. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 311. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 312. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 313. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY ONLINE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 314. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 315. UNITED STA

Companies Mentioned

  • AKAS Infusions
  • B. Braun SE
  • Baxter International, Inc.
  • Becton, Dickinson, and Company
  • Debiotech S.A.
  • Eitan Medical
  • Flowonix Medical Inc.
  • Fresenius Kabi AG
  • Fresenius SE & Co. KGaA
  • Halyard Health, Inc.
  • ICU Medical Inc.
  • Insulet Corporation
  • Intera Oncology Inc.
  • IRADIMED CORPORATION
  • Ivenix Inc.
  • Medtronic Plc
  • Micrel Medical Devices SA
  • Microport Scientific Corporation
  • MOOG, Inc.
  • Promecon GmbH
  • SINO MDT
  • Smiths Group plc
  • Tandem Diabetes Care, Inc.
  • Teleflex Incorporated
  • Terumo Corporation

Methodology

Loading
LOADING...

Related Topics

Related Reports

Drug Infusion System - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Drug Infusion System - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Home Infusion Services Market by Product, Indication, Application - Global Forecast 2025-2030 - Product Image

Home Infusion Services Market by Product, Indication, Application - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
Infusion Pumps Market by Product, Mode, Operation, Application, End User - Global Forecast 2025-2030 - Product Image

Infusion Pumps Market by Product, Mode, Operation, Application, End User - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Implantable Infusion Pumps - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Implantable Infusion Pumps - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Elastomeric Infusion Pumps Market Size, Share & Trends Analysis Report By Product, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Elastomeric Infusion Pumps Market Size, Share & Trends Analysis Report By Product, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From

About the Infusion System Market

The Infusion System market is a subset of the larger Infusions and Injectables market. It includes products and services related to the delivery of drugs, fluids, and other substances directly into a patient's bloodstream. This includes intravenous (IV) pumps, syringes, catheters, and other medical devices used to administer medications. It also includes the software and hardware used to monitor and control the delivery of these substances. The Infusion System market is a rapidly growing sector of the healthcare industry, driven by the increasing demand for more efficient and accurate delivery of medications. This demand is driven by the need for better patient outcomes, as well as the need to reduce healthcare costs. Some of the major players in the Infusion System market include Baxter International, B. Braun Melsungen AG, Fresenius Kabi, ICU Medical, Inc., and Smiths Medical. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.